173 related articles for article (PubMed ID: 19213780)
1. Superoxide dismutases, lung function and bronchial responsiveness in a general population.
Siedlinski M; van Diemen CC; Postma DS; Vonk JM; Boezen HM
Eur Respir J; 2009 May; 33(5):986-92. PubMed ID: 19213780
[TBL] [Abstract][Full Text] [Related]
2. Novel strategy to identify genetic risk factors for COPD severity: a genetic isolate.
van Diemen CC; Postma DS; Aulchenko YS; Snijders PJ; Oostra BA; van Duijn CM; Boezen HM
Eur Respir J; 2010 Apr; 35(4):768-75. PubMed ID: 19797132
[TBL] [Abstract][Full Text] [Related]
3. A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population.
van Diemen CC; Postma DS; Vonk JM; Bruinenberg M; Schouten JP; Boezen HM
Am J Respir Crit Care Med; 2005 Aug; 172(3):329-33. PubMed ID: 15879414
[TBL] [Abstract][Full Text] [Related]
4. A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology.
Gosman MM; Boezen HM; van Diemen CC; Snoeck-Stroband JB; Lapperre TS; Hiemstra PS; Ten Hacken NH; Stolk J; Postma DS
Thorax; 2007 Mar; 62(3):242-7. PubMed ID: 17090574
[TBL] [Abstract][Full Text] [Related]
5. Decorin and TGF-beta1 polymorphisms and development of COPD in a general population.
van Diemen CC; Postma DS; Vonk JM; Bruinenberg M; Nolte IM; Boezen HM
Respir Res; 2006 Jun; 7(1):89. PubMed ID: 16780585
[TBL] [Abstract][Full Text] [Related]
6. Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function.
Young RP; Hopkins R; Black PN; Eddy C; Wu L; Gamble GD; Mills GD; Garrett JE; Eaton TE; Rees MI
Thorax; 2006 May; 61(5):394-9. PubMed ID: 16467073
[TBL] [Abstract][Full Text] [Related]
7. Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease.
Juul K; Tybjaerg-Hansen A; Marklund S; Lange P; Nordestgaard BG
Am J Respir Crit Care Med; 2006 Apr; 173(8):858-64. PubMed ID: 16399992
[TBL] [Abstract][Full Text] [Related]
8. Lung function loss, smoking, vitamin C intake, and polymorphisms of the glutamate-cysteine ligase genes.
Siedlinski M; Postma DS; van Diemen CC; Blokstra A; Smit HA; Boezen HM
Am J Respir Crit Care Med; 2008 Jul; 178(1):13-9. PubMed ID: 18420959
[TBL] [Abstract][Full Text] [Related]
9. Alpha-nicotinic acetylcholine receptor and tobacco smoke exposure: effects on bronchial hyperresponsiveness in children.
Torjussen TM; Lødrup Carlsen KC; Munthe-Kaas MC; Mowinckel P; Carlsen KH; Helms PJ; Gerritsen J; Whyte MK; Lenney W; Undlien DE; Shianna KV; Zhu G; Pillai SG
Pediatr Allergy Immunol; 2012 Feb; 23(1):40-9. PubMed ID: 22017462
[TBL] [Abstract][Full Text] [Related]
10. Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.
Niu LM; Liang Y; Xu M; Zhang YY; Zhang Y; He B
Chin Med J (Engl); 2012 Jun; 125(12):2213-8. PubMed ID: 22884155
[TBL] [Abstract][Full Text] [Related]
11. Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals.
Bækvad-Hansen M; Nordestgaard BG; Dahl M
Eur Respir J; 2011 Apr; 37(4):791-9. PubMed ID: 20693256
[TBL] [Abstract][Full Text] [Related]
12. Association of glutathione-S-transferase omega haplotypes with susceptibility to chronic obstructive pulmonary disease.
Yanbaeva DG; Wouters EF; Dentener MA; Spruit MA; Reynaert NL
Free Radic Res; 2009 Aug; 43(8):738-43. PubMed ID: 19513904
[TBL] [Abstract][Full Text] [Related]
13. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study.
Garcia-Aymerich J; Lange P; Benet M; Schnohr P; Antó JM
Am J Respir Crit Care Med; 2007 Mar; 175(5):458-63. PubMed ID: 17158282
[TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferase genotype increases risk of progression from bronchial hyperresponsiveness to asthma in adults.
Imboden M; Rochat T; Brutsche M; Schindler C; Downs SH; Gerbase MW; Berger W; Probst-Hensch NM;
Thorax; 2008 Apr; 63(4):322-8. PubMed ID: 18057098
[TBL] [Abstract][Full Text] [Related]
15. [The relationship between bronchial hyperresponsiveness and chronic obstructive pulmonary disease].
Li Q; Xie G; Cheng X
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Oct; 24(10):584-7. PubMed ID: 11770417
[TBL] [Abstract][Full Text] [Related]
16. Smoke exposure interacts with ADAM33 polymorphisms in the development of lung function and hyperresponsiveness.
Reijmerink NE; Kerkhof M; Koppelman GH; Gerritsen J; de Jongste JC; Smit HA; Brunekreef B; Postma DS
Allergy; 2009 Jun; 64(6):898-904. PubMed ID: 19236319
[TBL] [Abstract][Full Text] [Related]
17. Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD.
van den Berge M; Vonk JM; Gosman M; Lapperre TS; Snoeck-Stroband JB; Sterk PJ; Kunz LI; Hiemstra PS; Timens W; Ten Hacken NH; Kerstjens HA; Postma DS
Eur Respir J; 2012 Nov; 40(5):1098-105. PubMed ID: 22523354
[TBL] [Abstract][Full Text] [Related]
18. Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program.
van den Boom G; van Schayck CP; van Möllen MP; Tirimanna PR; den Otter JJ; van Grunsven PM; Buitendijk MJ; van Herwaarden CL; van Weel C
Am J Respir Crit Care Med; 1998 Dec; 158(6):1730-8. PubMed ID: 9847260
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor 1 polymorphisms are associated with airway hyperresponsiveness and lung function decline, particularly in female subjects with asthma.
Dijkstra A; Howard TD; Vonk JM; Ampleford EJ; Lange LA; Bleecker ER; Meyers DA; Postma DS
J Allergy Clin Immunol; 2006 Mar; 117(3):604-11. PubMed ID: 16522460
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.
Danielsson P; Ólafsdóttir IS; Benediktsdóttir B; Gíslason T; Janson C
Clin Respir J; 2012 Apr; 6(2):120-7. PubMed ID: 21651748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
